You just read:

NKTR-181, A Mu-Opioid Analgesic With a Novel Molecular Structure, Demonstrates Slower Entry Rate Into the Brain and Reduced CNS Side Effects

News provided by

Nektar Therapeutics

Oct 15, 2010, 07:30 ET